The objective of this work was to investigate the distribution of prostate cancer using three-dimensional (3-D) computer simulation. Two hundred and eightyone 3-D computer prostate models were constructed from radical prostatectomy specimens. An algorithm was developed which divided each model into 24 symmetrical regions, and it then detected the presence of tumor within an individual region. The distribution rate of prostate cancer was assessed within each region of all 281 prostate models, and the difference between the rates was statistically analyzed using Mantel-Haenszel methodology. There was a statistically significant higher distribution rate of cancer in the posterior half (57.2%) compared to the anterior half ( 40.5%; P ¼ 0.001). The base regions (36.8%) had a statistically significant lower distribution rate than either the mid regions (56.3%; P ¼ 0.001) or the apical regions (53.5%; P ¼ 0.001). The mid regions did have a statistically significant higher distribution rate compared to the apical regions (P ¼ 0.032). There was no statistically significant difference between the distribution rate on the left half (48.5%) compared to that on the right half (49.2%; P ¼ 0.494). The spatial distribution of prostate cancer can be analyzed using 3-D computer prostate models. The results illustrate that prostate cancer is least commonly located in the anterior half and base regions of the prostate. Through an analysis of the spatial distribution of prostate cancer, we believe that new optimal biopsy strategies and techniques can be developed.
Introduction
The optimization of prostate biopsy protocols has been a goal of many centers over the last several years. The systematic sextant biopsy devised by Hodge et al revolutionized the way biopsies of the prostate were carried out, and became the standard of care. 1 In 1995, discussions began about performing sextant biopsies lateral to the midparasagiatal plane in order to sample more of the peripheral region. 2 The Stanford group had previously published that approximately 68% of cancers arise in the peripheral region, 24% in the transition region and 8% in the central region. 3 Eskew et al, introduced the five region biopsy technique in 1997, demonstrating that 17 (35%) of their 48 patients had carcinomas in additional regions that would have remained undetected with the standard sextant technique. 4 Rather than carrying out these new biopsy protocols on patients, some investigators chose to first carry out new biopsy schemes on computer prostate models. 5 Daneshgari et al had previously demonstrated in their computer simulation that only 20.3% of their prostate models had a tumor distribution for which the systematic sextant biopsy technique had a 95% probability of detecting the tumor. 6 In addition they found that 26.8% of the prostates had a tumor distribution that was completely disjointed from the six recommended biopsy regions. Crawford et al constructed 3-D computer prostate models using autopsy prostate specimens of patients with clinically undetected prostate cancer. They performed the standard sextant biopsies on these models, and determined that approximately only one-half of clinically significant prostate tumors were being detected by the above method. 7 The need to improve biopsy detection rates resulted in multiple centers developing computer-based simulations to evaluate biopsy protocols. Their results have clearly demonstrated that biopsy core placement can significantly improve cancer detection rate in computer based simulations. 8 -10 We have developed a computer simulated prostate biopsy model which has been used effectively to examine a variety of biopsy protocols. 10 -12 The results of our research suggested that lateral biopsies taken in the mid and apical regions were most important in improving the cancer detection rate. 10 In our pursuit to further optimize prostate biopsy protocols, we began to investigate the spatial distribution of prostate tumors. Goto et al had suggested that new biopsy strategies could be developed based on probability maps of cancer distribution within the prostate. 13 This was confirmed when Chen et al mapped and determined the location of tumor foci from 40 cases in which sextant biopsies did not reliably detect the tumor. 14 His group ultimately used these maps to devise a new biopsy strategy which incorporated these alternate areas and improved the cancer detection rate in 36 of 110 patients (33%). 15 We analyzed 281 3-D prostate models, and divided each model into 24 anatomical regions. Based on the location of the tumor within each region we have developed a distribution map of prostate cancer. We now report on the results of our distribution map, and its potential clinical utilities.
Materials and methods
We constructed 281 3-D prostate models from radical prostatectomy specimens. All prostates were step-sectioned in 4 mm sections at 2.25 mm intervals, and each slice was segmented by a pathologist to identify key pathologic structures, which included surgical margin, capsule, urethra, seminal vesicles and tumor. The contours of each structure were identified on each slice and stacked along the axial direction. Interpolation between the contours was carried out using a 3-D elastic model based technique. 16 Following interpolation, the 3-D computerized prostate models were constructed with internal structures using an SGI Onyx Infinite Reality 10 000 Workstation.
We developed an algorithm that divided each prostate model into 24 symmetric regions, and it also detected the presence of tumor within an individual region. 17 Figure 1 illustrates an example of a prostate model with a 24-region division. The labeling of each region follows current clinical conventions. The four layers of regions which lie parallel to the YZ plane (sagittal), and are labeled along the positive X direction are: left lateral (LL), left medial (LM), right medial (RM), and right lateral (RL). The three layers of regions which lie parallel to the XY plane (axial), and are labeled along the positive Z direction are: base, mid and apex. Similarly, the two layers which lie parallel to the XZ plane (coronal), and are labeled along the positive Y direction are: posterior (P) and anterior (A). Therefore, viewing the prostate model in axial view, this algorithm divides the prostate into four symmetric compartments sideways, two symmetric compartments vertically, and three symmetric compartments in depth. The size of each region varies with the size of the prostate model. Although larger prostates had larger individual regions, each corresponding region in different prostate models carried the same spatial meaning and was treated equally regardless of size.
The distribution of prostate cancer was then assessed within each region of all 281 prostate models. A region was considered positive if at least part of a tumor, regardless of its volume and location, was found within a region. The presence, or lack of tumor within each region for all 281 prostates was calculated. These calculations were used to determine the spatial distribution of prostate cancer in our series. Mantel-Haenszel methodology was used to determine if the differences in tumor positivity rates between regions were statistically significant. Chi-square statistics with adjustments for patients were computed to test the null hypothesis of homogeneity of zonal positivity rates.
Results
The patient characteristics of the constructed 3-D computer prostate models are outlined in Table 1 . The average prostate specific antigen (PSA) was 10.3, the median was 7.3, 70.3% of the cohort had a PSA <10, and 29.7% had a PSA >10. The mean Gleason sum was 6.4, where 46.4% of the cohort had a Gleason sum <7, 40.4% had a Gleason sum equal to 7, and 13.2% had a Gleason sum >7.
The positivity rates for regions within the left/right, and anterior/posterior halves of the prostate are graphed in Figure 2 . In the posterior half, the medial regions Investigating the distribution of prostate cancer MB Opell et al always had a higher distribution of cancer than the lateral regions. In the anterior half, the medial regions did not have a higher distribution of cancer than the lateral regions in all cases. When the mid regions were compared to the apical regions, the mid regions always had a higher distribution of cancer in the posterior half. However for the anterior half, both the right and left medial apical regions had a higher distribution of cancer than the corresponding medial mid regions. When the base regions were compared to their corresponding mid or apex regions, the distribution of cancer was always lower in the base regions for both the anterior and posterior halves.
There were 3295 tumor-positive regions out of 6744 total regions (24 regions multiplied by 281 models) for a positivity rate of 48.9%. In the sagittal view, the positivity rates were 46.2% in the left lateral, 50.8% in the left medial, 50.5% in the right medial, and 47.9% in the right lateral regions. Positivity was not significantly different between the left and right medial regions (P ¼ 0.876) or between the left and right lateral regions (P ¼ 0.271). The 50.6% positivity for the left and right medial regions combined was significantly higher than the 47.1% positivity for the left and right lateral regions combined (P ¼ 0.001; Table 2 ). The 48.5% positivity for the left lateral and left medial regions combined was insignificantly different from the 49.2% positivity for the right lateral and right medial regions combined (P ¼ 0.494). In the coronal view, there was a statistically significant difference in positivity for posterior (57.2%) and anterior (40.5%) regions (P ¼ 0.001; Table 2 ). In the axial view, positivity was 36.8% for base regions, 56.3% for mid regions, and 53.5% for apex regions. The positivity rates among all three regions were significantly different from each other, base vs mid and base vs apex at the P ¼ 0.001 level, and mid vs apex at the P ¼ 0.032 level ( Table 2) .
Discussion
We devised a spatial distribution map for prostate cancer by dividing each prostate into 24 regions. We chose 24 regions because it appeared that this division scheme would be detailed enough to provide useful distribution information, but simple enough to be easily interpreted. The medial regions start as medial as the midline of the prostate, and go as lateral as halfway between the midline and the most lateral aspect of the prostate. Thus, these regions can contain tumors that could be detected by standard sextant biopsies. The lateral regions start medially at the halfway point between the midline and most lateral aspect of the prostate, and extend to the lateral edge of the prostate. Thus, these regions can contain tumors that could be detected by more laterally directed prostate biopsies. The most recent clinical studies have recommended that not only should the total number of biopsy cores be increased, but half of the total cores taken should be directed more laterally. 18 Based on the recent emphasis of performing laterally directed biopsies secondary to their higher yield, one might have expected the lateral regions to have the highest distribution rate of cancer. This was not confirmed in our study. Figure 2 illustrates that in nine of 12 instances the medial region had a greater than or equal positivity rate than its corresponding lateral region. This resulted in the statistically significant higher tumor distribution rate that was present in the combined medial regions ( Table 2) .
Despite these results, we cannot conclude that prostate cancer is more commonly located in the medial regions. First, our models are from radical prostatectomy specimens that were collected between 1989 and 1995. The majority of the cancers were detected by either lesion directed or sextant techniques, which could have contributed to the predominance of cancer found in the medial regions. Currently, new prostate models are being constructed from a more recent database, and will be included in future analysis.
Secondly, as observed in Figure 1 , there is prostate contained within each region of our 24-region algorithm, however there is less prostate within the lateral regions as compared to the medial regions. This is especially true at the apex where the prostate is most narrow. If there is less prostate within a particular region, then there will probably be a lesser chance of tumor being found within that region. As a result of the algorithm not taking this into consideration, this could likely have altered our results. Therefore, this might account for the statistically significant higher amount of cancer in the medial regions compared to the lateral regions, and in the mid regions compared to the apical regions. A possible solution to this problem would be to develop an algorithm that better conforms to the actual shape of the prostate, so that there are similar amounts of prostate within all regions. Even with these limitations, we do believe that our results illustrate that there is a large amount of cancer located in the lateral regions. This is especially evident in the posterior apex and mid regions. We had confirmed this previously when our models were used to compare various biopsy protocols. In that study, the standard sextant biopsy pattern had a detection rate of 72.6%, and four-pattern biopsy consisting of R/L lateral mid and apex biopsies had a detection rate of 93.5%. 10 One of the more significant findings in our study was that the base regions of the prostate had the lowest distribution of cancer (Table 2) . Interestingly, this occurred in all cases despite the relatively larger amount of prostate located in the base region as compared to the apical region. This difference between regions, as outlined in Table 2 , was uniformly statistically significant. Based on these results an argument could be made that both the lateral and medial base biopsies are of the lowest yield when performing current systematic prostate biopsies. The irony is that this region of the prostate is probably the easiest to sample when using transrectal ultrasound. There is a clinical study that in part supports these findings. Presti et al have recently published that their medial lobar base biopsies had the lowest yield, and they recommended eliminating them from a 10-biopsy pattern protocol. 18 Although their study did not examine lateral apex biopsies, they recommended that lateral base and lateral mid-gland biopsies be performed. Further prospective clinical studies should be carried out to examine the yield of both lateral and medial base prostate biopsies.
The low distribution of cancer located in the anterior half of our models was consistent with past pathologic zonal distribution studies. 3 The anteromedial aspect of our models most likely incorporates the transition region of the prostate. As stated earlier, approximately 24% of prostate cancers arise in the transition region. 3 Although a statistically significant higher proportion of cancer was located in the posterior half, it is evident from our distribution map that the anterior region is worth sampling. Based on the information from our models, these biopsies might be best taken in the medial/mid regions of the prostate. The distribution of cancer located in the anterior base regions only ranged from 28.1% to 32.0%. The low proportion of cancer in the anterobasal regions is probably explained by the fact that this is where the central region of the prostate is located. The central region has been shown previously to have the lowest proportion of cancer within the prostate. 19 Our study also illustrates that there is no significant difference in the distribution of cancer located on the left compared to that located on the right. A recent study that mapped prostate cancer distributions using 81 radical prostate specimens observed a higher frequency of cancer in the left half of the prostate. 20 They could not confirm these observed findings with statistical significance, but did state that this should be investigated further. Although their model appears to be a valid one, they do admit that their sample size should be larger. We also believe that our sample size needs to be increased. The addition of new prostate models to our algorithm could significantly improve the power of our results.
Conclusions
The spatial distribution of prostate cancer can be analyzed using 3-D computer prostate models. We plan to develop additional distribution maps to determine if differences in Gleason sum, PSA, or race significantly alter the general distribution of prostate cancer. Our map indicates that prostate cancer is more commonly found in the posterior half, the apical, and the mid regions of the prostate. Through the accumulation of more models and further refinement of our algorithm, the most accurate map can be developed. This map can eventually be used to develop optimal biopsy protocols. These protocols can be formulated based upon the objective of achieving at least one positive core during the sampling of a specific combination of regions. Future research will concentrate on the development and testing of these optimized protocols to determine if they truly improve detection rates. If these new optimized biopsy protocols are found to improve detection rates, they could one day be incorporated into an in vivo online transrectal ultrasound biopsy system that could help guide the urologist as to which regions of the prostate they should sample.
